(Q73044362)
Statements
Rituximab chimeric anti-CD20 monoclonal antibody treatment for refractory hemolytic anemia in patients with lymphoproliferative disorders (English)
Giulio Trapè
Luana Fianchi
Marco Lai
Luca Laurenti
Roberta Piscitelli